Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication.
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studiesMethylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder.Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in miceMethylphenidate improves motor functions in children diagnosed with Hyperkinetic Disorder.Reinforcement and Stimulant Medication Ameliorate Deficient Response Inhibition in Children with Attention-Deficit/Hyperactivity Disorder.An integrative approach to determine the best behavioral and biological markers of methylphenidate.Having a goal to stop action is associated with advance control of specific motor representations.Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate.Executive function in pediatric bipolar disorder and attention-deficit hyperactivity disorder: in search of distinct phenotypic profiles.Prosocial skills may be necessary for better peer functioning in children with symptoms of disruptive behavior disordersPerceptual and motor inhibition in adolescents/young adults with childhood-diagnosed ADHD.A developmental window into trade-offs in executive function: the case of task switching versus response inhibition in 6-year-oldsSeparating automatic and intentional inhibitory mechanisms of attention in adults with attention-deficit/hyperactivity disorder.Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats.Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis.Catecholamine influences on dorsolateral prefrontal cortical networks.Effects of behavioral and pharmacological therapies on peer reinforcement of deviancy in children with ADHD-only, ADHD and conduct problems, and controlsStriatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjectsAnimal models to guide clinical drug development in ADHD: lost in translation?Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity.Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD?Prenatal Nicotine Exposure Impairs Executive Control Signals in Medial Prefrontal Cortex.Stimulants: Therapeutic actions in ADHD.1H MRSI of middle frontal gyrus in pediatric ADHDAcute effects of cocaine on the neurobiology of cognitive control.Inhibitory processes in young children and individual variation in short-term memoryNeuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function.Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition.Neuropsychological analyses of comorbidity between reading disability and attention deficit hyperactivity disorder: in search of the common deficit.Right prefrontal activation as a neuro-functional biomarker for monitoring acute effects of methylphenidate in ADHD children: An fNIRS study.The interplay between executive control and motor functioning in Williams syndrome.Anxiety, methylphenidate response, and working memory in children with ADHD.Methylphenidate effects on neural activity during response inhibition in healthy humans.Task demands interact with the single and combined effects of medication and contingencies on children with ADHD.Motor impulsivity in Parkinson disease: associations with COMT and DRD2 polymorphisms.A comprehensive assessment of memory, delay aversion, timing, inhibition, decision making and variability in attention deficit hyperactivity disorder: advancing beyond the three-pathway models.Stop the presses: dissociating a selective from a global mechanism for stopping.Efficacy and Tolerability of Different Interventions in Children and Adolescents with Attention Deficit Hyperactivity Disorder.
P2860
Q22061981-6AEE1009-730F-4DC8-AB71-DCAC9E5569D7Q24671982-D884963A-525E-4F3A-91B9-DA84D66311C2Q24810310-754D4A8D-1197-48B6-A3F1-BEF82DA3EE1EQ30446313-F1901E98-0898-454C-A7B0-58355CE1D51FQ30487808-84D555C6-2917-4131-AF02-0FB357FBC1FEQ30680214-5E45DE60-AE5C-4531-9971-E1258305214AQ33283331-E690EB16-734D-40A3-A1C6-6F0D22EB3CF6Q33620778-5120F187-9E7A-4DB2-B41B-6640DCA5767AQ33678909-8068AAF2-444B-436D-B2F6-B61CA6D42517Q33712119-83C56407-E930-4516-A955-5A6396761212Q33930655-450A9CF8-537C-4354-8EBB-E7C47AC66FFBQ33978588-7B391CEE-3A41-4FCA-8211-CC966268E8CCQ34203236-AFF05E78-A220-461B-8587-7969436776A7Q34730792-BDFBD112-47B8-453C-8DE0-F4C67773EECDQ34797544-BEE07B8C-198F-4DE3-BC40-43526E3FF244Q35110705-F2799E5B-0D01-46CA-B4E9-8B262FA5C7B0Q35132548-0BA43B46-78DE-4BB2-8050-4116E08CE40AQ35235902-3B8CD28E-C705-425F-9CD3-E5D7FB2D48F6Q35423597-0B376706-C428-416C-8050-523B8B3F2F6AQ35589937-CF5B4313-7E77-47B7-A792-598158E10829Q35785190-B8468363-1F38-46C8-82C8-6A4E3A724482Q36171367-178E4E72-DA01-4DAF-9344-A79835CC8E71Q36449661-69711E70-7A36-426A-B40D-BCAC2E710E49Q36541590-CC607010-FE5F-4850-8303-C3410DCB759EQ36720847-ADE9A364-2CBD-43C5-A1ED-B6CD5B783DB0Q37024187-296FF969-54AA-495E-8D1C-B70661D4ACF6Q37193117-F865A0AA-1F6C-42D8-8C7D-785ACA1480A0Q37203807-EE519573-4BF7-492C-97BC-B9A9CEA1ABEAQ37390217-24398C32-2DD7-45E6-9543-93BD0CC3FE86Q37554913-58562E2C-7FD0-40D6-9C0B-BEDF22B8196EQ40442012-98E6F54C-615E-450F-BC56-9E971B5669B0Q42577413-DD9CFCF5-4D3B-470C-94D9-E771699FC5BAQ44056677-2C2D35FE-52DF-45E9-9C26-1A875A016940Q44503273-C976A2DC-B969-43D4-8F6F-1FB0908B07FFQ44793419-E945ECAA-668A-492C-AF48-085490DB5CCFQ46075635-EC28068B-4BF2-40ED-B1ED-54979D46AECCQ46205987-7BECD662-7A69-4CF3-A9FA-6A26C0FAEDA5Q46323179-3C701E8F-8006-4A74-9477-4ED6B54512EAQ46402090-3B900354-D444-494F-8953-298A47BE33AAQ46584563-CBFD7AE6-3D7E-4582-88B8-37C8AAD94FA0
P2860
Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Selective inhibition in childr ...... f and on stimulant medication.
@en
Selective inhibition in childr ...... f and on stimulant medication.
@nl
type
label
Selective inhibition in childr ...... f and on stimulant medication.
@en
Selective inhibition in childr ...... f and on stimulant medication.
@nl
prefLabel
Selective inhibition in childr ...... f and on stimulant medication.
@en
Selective inhibition in childr ...... f and on stimulant medication.
@nl
P2093
P356
P1476
Selective inhibition in childr ...... f and on stimulant medication.
@en
P2093
Abel Ickowicz
Anne-Claude Bedard
Gordon D Logan
Rosemary Tannock
P2888
P304
P356
10.1023/A:1023285614844
P577
2003-06-01T00:00:00Z
P6179
1029887058